Private equity firm True North fully exited Zydus Wellness by selling its entire 7.27% stake, comprising 46.27 lakh shares, for ₹879 crore through an open market transaction on June 17, 2025. The shares were sold via its affiliate Threpsi Care LLP at an average price of ₹1,900 each, with PPFAS Mutual Fund acquiring the stake. Previously, True North had reduced its holding in Zydus Wellness through sales in December 2023 (1.23% for ₹127 crore) and August 2024 (2.6% for ₹374 crore). Zydus Wellness, a consumer goods company focused on health and wellness products like Glucon-D and Nutralite, saw its share price rise 1.16% to ₹1,935.60 on the NSE following the transaction.